Yan Jianlong, Pan Yanbin, Liu Huadong, Yuan Jie, Chen Jie, Gao Yannan, Lin Chaolan, Lin Feng, Wang Rongning, He Yaqiong, Wang Caiping, Xu Cong, Li Tangzhiming, Zhang Peng, Lan Yu, Shao Wenming, Pang Xinli, Yin Da, Sun Xin, Luo Weixiang
Department of Cardiology, Shenzhen Cardiovascular Minimally Invasive Medical Engineering Technology Research and Development Center, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, China.
Department of Health Management Center, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, China.
Front Microbiol. 2025 Jul 30;16:1622488. doi: 10.3389/fmicb.2025.1622488. eCollection 2025.
Bisphenol F (BPF), a common substitute for bisphenol A (BPA), has documented toxicity in multiple organs, but its vascular effects remain unclear. This study investigated BPF's role in vascular calcification (VC) and underlying mechanisms.
Differences in the intestinal microbiota were analyzed by 16S ribosomal RNA gene sequencing. Metabolites were analyzed using liquid chromatography-mass spectrometry. Faecal microbiota transplantation and antibiotic treatment experiments were performed to evaluate the functions of the intestinal microbiota in VC.
We enrolled consecutively 57 patients. Patients were assigned to a calcification group (30 patients) and a non-calcification group (27 patients) based on the presence or absence of calcification in the thoracic aorta wall. The results showed that patients with vascular calcification (VC) had higher levels of bisphenol F (BPF), bisphenol S (BPS) and bisphenol A (BPA) in the fecal samples than patients without VC. The thoracic aortic calcification score was significantly positively correlated with the BPF (Spearman = 0.4935, < 0.001), BPA (Spearman = 0.2860, < 0.05) and BPS (Spearman = 0.2650, < 0.05). We then explored the effects of BPF exposure on normal and vitamin D3 + nicotine (VDN)-treated rats. BPF exposure induced mild VC in normal rats and aggravated VC in VDN-treated rats. BPF exposure disturbed the gut microbiota and promoted inflammatory responses.
The results here elucidate the mechanism underlying BPF-triggered or BPF-aggravated VC through the gut-vascular axis and provide a theoretical basis for cardiovascular disease risk assessment in humans.
双酚F(BPF)是双酚A(BPA)的常见替代品,已被证明对多个器官具有毒性,但其对血管的影响仍不清楚。本研究调查了BPF在血管钙化(VC)中的作用及其潜在机制。
通过16S核糖体RNA基因测序分析肠道微生物群的差异。使用液相色谱-质谱法分析代谢物。进行粪便微生物群移植和抗生素治疗实验,以评估肠道微生物群在VC中的功能。
我们连续招募了57名患者。根据胸主动脉壁是否存在钙化,将患者分为钙化组(30例)和非钙化组(27例)。结果显示,血管钙化(VC)患者粪便样本中的双酚F(BPF)、双酚S(BPS)和双酚A(BPA)水平高于无VC患者。胸主动脉钙化评分与BPF(Spearman = 0.4935,<0.001)、BPA(Spearman = 0.2860,<0.05)和BPS(Spearman = 0.2650,<0.05)显著正相关。然后,我们探讨了BPF暴露对正常大鼠和维生素D3 + 尼古丁(VDN)处理大鼠的影响。BPF暴露在正常大鼠中诱导轻度VC,并在VDN处理的大鼠中加重VC。BPF暴露扰乱了肠道微生物群并促进了炎症反应。
本研究结果阐明了BPF引发或加重VC的机制,通过肠-血管轴,为人类心血管疾病风险评估提供了理论依据。